Literature DB >> 17486614

Recurrent interstitial deletions of proximal 18q: a new syndrome involving expressive speech delay.

Jannine D Cody1, Courtney Sebold, Amtul Malik, Patricia Heard, Erika Carter, Analisa Crandall, Bridgette Soileau, Margaret Semrud-Clikeman, Catherine M Cody, L Jean Hardies, Jinqi Li, Jack Lancaster, Peter T Fox, Robert F Stratton, Brian Perry, Daniel E Hale.   

Abstract

Most deletions of the long arm of chromosome 18 involve some part of the most distal 30 Mb. We have identified five individuals with cytogenetically diagnosed interstitial deletions that are all proximal to this commonly deleted region. The extent of their deletions was characterized using molecular and molecular cytogenetic techniques. Each participant was assessed under the comprehensive clinical evaluation protocol of the Chromosome 18 Clinical Research Center. Three of the five individuals were found to have apparently identical interstitial deletions between positions of 37.5 and 42.5 Mb (18q12.3-->18q21.1). One individual's deletion was much larger and extended from a more proximal breakpoint position of 23 Mb (18q11.2) to a more distal breakpoint at 43 Mb (18q21.1). The fifth individual had a proximal breakpoint identical to the other three, but a distal breakpoint at 43.5 Mb (18q21.1). The clinical findings were of interest because the three individuals with the smaller deletions lacked major anomalies. All five individuals were developmentally delayed; however, the discrepancy between their expressive and receptive language abilities was striking, with expressive language being much more severely affected. This leads us to hypothesize that there are genes in this region of chromosome 18 that are specific to the neural and motor planning domains necessary for speech. Additionally, this may represent a previously underappreciated syndrome since these children do not have the typical clinical abnormalities that would lead to a chromosome analysis. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17486614     DOI: 10.1002/ajmg.a.31729

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Chromosome 18 gene dosage map 2.0.

Authors:  Jannine D Cody; Patricia Heard; David Rupert; Minire Hasi-Zogaj; Annice Hill; Courtney Sebold; Daniel E Hale
Journal:  Hum Genet       Date:  2018-11-17       Impact factor: 4.132

2.  Split Hand/Foot Malformation Associated with 7q21.3 Microdeletion: A Case Report.

Authors:  Aswini Sivasankaran; Ambika Srikanth; Pooja S Kulshreshtha; Deenadayalu Anuradha; Jayarama S Kadandale; Chandra R Samuel
Journal:  Mol Syndromol       Date:  2016-02-03

3.  Genetic determinants of autism in individuals with deletions of 18q.

Authors:  Louise O'Donnell; Bridgette Soileau; Patricia Heard; Erika Carter; Courtney Sebold; Jon Gelfond; Daniel E Hale; Jannine D Cody
Journal:  Hum Genet       Date:  2010-05-25       Impact factor: 4.132

4.  A Novel SETBP1 Gene Disruption by a De Novo Balanced Translocation in a Patient with Speech Impairment, Intellectual, and Behavioral Disorder.

Authors:  Ivona Vrkić Boban; Futoshi Sekiguchi; Mirela Lozić; Noriko Miyake; Naomichi Matsumoto; Bernarda Lozić
Journal:  J Pediatr Genet       Date:  2020-08-31

5.  Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development.

Authors:  Lilit Antonyan; Carl Ernst
Journal:  Front Neurosci       Date:  2022-05-24       Impact factor: 5.152

6.  Establishing a reference group for distal 18q-: clinical description and molecular basis.

Authors:  Jannine D Cody; Minire Hasi; Bridgette Soileau; Patricia Heard; Erika Carter; Courtney Sebold; Louise O'Donnell; Brian Perry; Robert F Stratton; Daniel E Hale
Journal:  Hum Genet       Date:  2013-10-05       Impact factor: 4.132

Review 7.  Rit subfamily small GTPases: regulators in neuronal differentiation and survival.

Authors:  Geng-Xian Shi; Weikang Cai; Douglas A Andres
Journal:  Cell Signal       Date:  2013-06-11       Impact factor: 4.315

8.  Narrowing critical regions and determining penetrance for selected 18q- phenotypes.

Authors:  Jannine D Cody; Patricia L Heard; Analisa C Crandall; Erika M Carter; John Li; L Jean Hardies; Jack Lancaster; Brian Perry; Robert F Stratton; Courtney Sebold; Rebecca L Schaub; Bridgette Soileau; Annice Hill; Minire Hasi; Peter T Fox; Daniel E Hale
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

9.  Clinical interpretation of CNVs with cross-species phenotype data.

Authors:  Sebastian Köhler; Uwe Schoeneberg; Johanna Christina Czeschik; Sandra C Doelken; Jayne Y Hehir-Kwa; Jonas Ibn-Salem; Christopher J Mungall; Damian Smedley; Melissa A Haendel; Peter N Robinson
Journal:  J Med Genet       Date:  2014-10-03       Impact factor: 6.318

10.  Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice.

Authors:  Wenzhi Sun; Jacy L Wagnon; Connie L Mahaffey; Michael Briese; Jernej Ule; Wayne N Frankel
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.